Deutsch
TU Dresden

search
UniStem Day 2019
Participation in international action day on stem cell research [read more]
© CRTD
A new generation of focused future thinkers
Researchers from TU Dresden discover protein for more mobility [read more]
Prof. Dr. Martina Rauner and Dr. Ulrike Baschant © Stephan Wiegand
Prof. Michael Brand is the new institute director of the CRTD
Prof. Dr. Michael Brand is the new Director of the Center for Regenerative Therapies (CRTD) at TU Dresden. [read more]
Prof. Ezio Bonifacio, PhD & Prof. Dr. Michael Brand © CRTD
Knowledge builds bridges: Duke of Kent visits TU Dresden
Today (11th February 2019), Technische Universität Dresden (TUD) welcomed His Royal Highness Prince Edward, Duke of Kent. [read more]
© Marc Eisele/Universitätsklinikum Dresden
Top diabetes researcher becomes Honorary Professor at CRTD / TU Dresden
Rector appoints Matthias Hebrok Honorary Professor in "Cell Biology of the Pancreas" at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University [read more]
Prof. Hebrok © CRTD
Type 1 diabetes is the spotlight of Germany-wide awareness campaign
A campaign that will cause a stir: since 22 January, "Sche1sstyp" has been prominently displayed in large letters on over 1000 posters throughout Germany. [read more]
Kick-off event in Berlin © Foto: Helmholtz Zentrum München / Dirk Deckbar
Building a solid perspective on scientific career
Dr. Tatiana Sandoval-Guzmán is one of the mentees of the Maria Reiche Mentoring Program and speaks about her experiences in the new edition of the TU Dresden Journal [read more]
Dr. Tatiana Sandoval-Guzmán © CRTD
Dr. Mareike Albert is new research group leader at the CRTD
Dr. Mareike Albert is a new research group leader at the Center for Regenerative Therapies (CRTD) at TU Dresden. [read more]
Dr. Mareike Albert © CRTD

Research at the Center for Regenerative Therapies (CRTD) at TU Dresden focuses on discovering principles of cell and tissue regeneration, and leveraging this for recognition, treatment, and reversal of diseases. The CRTD is well positioned for this challenge with its diversity in model organisms, organs, and disease systems and its range of methodological approaches from basic research to validation projects and clinical studies. The CRTD links the bench to the clinic, and scientists to clinicians to bring expertise in stem cells, gene-editing, and regeneration towards innovative therapies for metabolic, osteo-hematological, and neurological diseases.